Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Local Stocks
San Gabriel Valley Index
San Gabriel Valley
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Abcellera Biologics Inc
(NQ:
ABCL
)
2.610
-0.010 (-0.38%)
Streaming Delayed Price
Updated: 4:00 PM EDT, Aug 16, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Abcellera Biologics Inc
< Previous
1
2
3
4
5
6
7
8
9
Next >
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
November 01, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Prelude Therapeutics and AbCellera Enter Partnership to Develop First-in-Class Precision Antibody Drug Conjugates in Oncology
November 01, 2023
Multi-year collaboration to jointly discover, develop, and commercialize novel oncology medicines for up to five programs, with the first ADC program focusing on a SMARCA degrader
From
Prelude Therapeutics, Inc.; AbCellera
Via
GlobeNewswire
Earnings Preview: AbCellera Biologics
August 02, 2023
Via
Benzinga
Recap: AbCellera Biologics Q1 Earnings
May 04, 2023
Via
Benzinga
AbCellera to Present at the Jefferies London Healthcare Conference on November 14, 2023
October 31, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Report Third Quarter 2023 Financial Results on November 2, 2023
October 11, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces Two T-Cell Engager Presentations at SITC 2023
September 27, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Argenx's 28% Surge & Promising Product Propel Investor Confidence
September 25, 2023
Argenx's chart is forming a bullish base after a 28% jump after positive clinical trials. Analysts believe the immunology specialist is an acquisition target.
Via
MarketBeat
AbCellera Expands Multi-Target Antibody Discovery Collaboration with Regeneron
September 20, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces Collaboration with Incyte to Accelerate the Discovery and Development of Therapeutic Antibodies in Oncology
September 13, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Why AbCellera Biologics Is Still A Buy Despite Dropping Royalties: Analyst On Long-Term Prospects
August 31, 2023
Benchmark analyst Robert Wasserman reiterated a Buy rating on AbCellera Biologics Inc. (NASDAQ: ABCL),
Via
Benzinga
3 AI Stocks You’ll Regret Not Buying Soon
August 08, 2023
AI will have a big impact on biotech, which could help with drug discovery and create opportunities for these top AI stocks to invest in.
Via
InvestorPlace
Why ResMed Shares Are Trading Lower By 15%? Here Are Other Stocks Moving In Friday's Mid-Day Session
August 04, 2023
Gainers Missfresh Limited (NASDAQ: MF) jumped 168% to $1.38 after the company announced entry of share purchase agreements for financing and business acquisition.
Via
Benzinga
Apple, Fortinet, Microchip Technology And Other Big Stocks Moving Lower In Friday's Pre-Market Session
August 04, 2023
U.S. stock futures traded higher this morning on Friday. Here are some big stocks recording losses in today’s pre-market trading session.
Via
Benzinga
AbCellera Biologics (ABCL) Q2 2023 Earnings Call Transcript
August 04, 2023
ABCL earnings call for the period ending June 30, 2023.
Via
The Motley Fool
12 Health Care Stocks Moving In Thursday's After-Market Session
August 03, 2023
Via
Benzinga
AbCellera Reports Q2 2023 Business Results
August 03, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Announces that the U.S. Patent Trial and Appeal Board Has Denied Berkeley Lights’ Request for Rehearing
July 24, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Why Lucid Group Shares Are Trading Lower By 11%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
July 12, 2023
Gainers Healthcare Triangle, Inc. (NASDAQ: HCTI) shares climbed 171.2% to $8.84 as the company launched initiative to prevent ransomware attacks in the $35 billion healthcare data market.
Via
Benzinga
InMode, Daktronics, Domino's Pizza And Other Big Stocks Moving Higher On Wednesday
July 12, 2023
U.S. stocks traded higher, with the Dow Jones gaining around 250 points on Wednesday. Here are some big stocks recording gains in today’s session.
Via
Benzinga
Looking for Biotech AI Stocks? 3 Names That Will Benefit From the AI Boom
July 08, 2023
AI is changing the face of biotechnology and drug discovery. Don't miss out on the next big boom in biotech, here are 3 stocks to consider.
Via
InvestorPlace
AbCellera to Report Second Quarter 2023 Financial Results on August 3, 2023
July 06, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera to Present at the Goldman Sachs 44th Annual Global Healthcare Conference on June 13, 2023
May 29, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
AbCellera Partners with the Governments of Canada and British Columbia to Advance Drug Development Capabilities and Infrastructure that Will Accelerate Innovative Medicines to Patients
May 24, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
Why CohBar Shares Are Trading Lower By 161%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
May 23, 2023
Gainers
Via
Benzinga
7 Growth Stocks That Could Double Your Money in 2023
May 14, 2023
For investors that really want to roll the dice, these are the enticing growth stocks that could double your money.
Via
InvestorPlace
AbCellera Biologics (ABCL) Q1 2023 Earnings Call Transcript
May 05, 2023
ABCL earnings call for the period ending March 31, 2023.
Via
The Motley Fool
AbCellera Reports Q1 2023 Business Results
May 04, 2023
From
AbCellera Biologics Inc.
Via
Business Wire
How AI Is Revolutionizing Tech, and Why You Should Invest in These Leading Companies
April 28, 2023
Check out these compelling opportunities.
Via
The Motley Fool
7 Stocks Under $10 That Analysts Love
April 24, 2023
While these ideas might seem super cheap in a bad way, these stocks under $10 also rank among Wall Street analysts’ top picks.
Via
InvestorPlace
< Previous
1
2
3
4
5
6
7
8
9
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.